Troyanovsky R B, Chitaev N A, Troyanovsky S M
Department of Dermatology, Washington University Medical School, St Louis, MO 63110, USA.
J Cell Sci. 1996 Dec;109 ( Pt 13):3069-78. doi: 10.1242/jcs.109.13.3069.
Plakoglobin directly interacts with cadherins and plays an essential role in the assembly of adherens junctions and desmosomes. Recently we have reported that multiple cadherin binding sites are localized along the arm repeat region of plakoglobin. To demonstrate functionally and specificity of these sites in vivo we constructed a set of chimeric proteins containing a plakoglobin sequence fused with the transmembrane vesicular protein synaptophysin. Plakoglobin fused upstream or downstream from synaptophysin (PgSy and SyPg, chimeras, respectively) is exposed on the cytoplasmic surface of synaptic-like vesicles and is able to associate with E-cadherin, and with two desmosomal cadherins, desmoglein and desmocollin. Moreover, plakoglobin targets these vesicles to cell-cell junctions. Insertion of synaptophysin within plakoglobin (PSyG chimeras) can interfere with cadherin binding of the resulting chimeric proteins, dependent on the position of the insertion. Insertion of synaptophysin in the first three arm repeats selectively inactivates plakoglobin binding to desmoglein and desmocollin. An insertion of synaptophysin within the next two repeats inactivates E-cadherin and desmocollin binding but not desmoglein binding. This localization of the desmoglein and E-cadherin binding sites was further confirmed by replacement of plakoglobin arm repeats with the corresponding sequence derived from the plakoglobin homologue, beta-catenin, and by deletion mutagenesis. Insertion of synaptophysin in most sites within arm repeats 6-13 does not change plakoglobin binding to cadherins. It does, however, strongly inhibit association of the resulting vesicles either with desmosomes and adherens junctions or with desmosomes only. Using in vitro binding assays we demonstrate that arm repeats 6-13 contain two cryptic cadherin binding sites that are masked in the intact protein. These observations suggest that the arm repeat region of plakoglobin is comprises two functionally distinct regions: the 1/5 region containing desmoglein and E-cadherin specific binding sites and the 6/13 region implicated in targeting of plakoglobin/cadherin complexes into junctional structures.
桥粒斑珠蛋白直接与钙黏着蛋白相互作用,在黏着连接和桥粒的组装中起关键作用。最近我们报道,多个钙黏着蛋白结合位点定位于桥粒斑珠蛋白的臂重复区域。为了在体内证明这些位点的功能和特异性,我们构建了一组嵌合蛋白,其包含与跨膜囊泡蛋白突触素融合的桥粒斑珠蛋白序列。在突触素上游或下游融合的桥粒斑珠蛋白(分别为PgSy和SyPg嵌合体)暴露于类突触囊泡的细胞质表面,并且能够与E-钙黏着蛋白以及两种桥粒钙黏着蛋白桥粒芯糖蛋白和桥粒胶蛋白结合。此外,桥粒斑珠蛋白将这些囊泡靶向细胞间连接。突触素插入桥粒斑珠蛋白内(PSyG嵌合体)可干扰所得嵌合蛋白与钙黏着蛋白的结合,这取决于插入位置。突触素在前三个臂重复序列中的插入选择性地使桥粒斑珠蛋白与桥粒芯糖蛋白和桥粒胶蛋白的结合失活。突触素在接下来的两个重复序列中的插入使E-钙黏着蛋白和桥粒胶蛋白的结合失活,但不影响桥粒芯糖蛋白的结合。通过用源自桥粒斑珠蛋白同源物β-连环蛋白的相应序列替换桥粒斑珠蛋白臂重复序列以及缺失诱变,进一步证实了桥粒芯糖蛋白和E-钙黏着蛋白结合位点的这种定位。突触素插入臂重复序列6-13内的大多数位点不会改变桥粒斑珠蛋白与钙黏着蛋白的结合。然而,它确实强烈抑制所得囊泡与桥粒和黏着连接或仅与桥粒的结合。使用体外结合试验,我们证明臂重复序列6-13包含两个隐藏的钙黏着蛋白结合位点,这些位点在完整蛋白中被掩盖。这些观察结果表明,桥粒斑珠蛋白的臂重复区域包括两个功能不同的区域:包含桥粒芯糖蛋白和E-钙黏着蛋白特异性结合位点的1/5区域以及与将桥粒斑珠蛋白/钙黏着蛋白复合物靶向连接结构有关的6/13区域。